New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
March 15, 2017 – The FDA announced that Allergan’s Viberzi (eluxadoline) should not be used in patients who do not have a gallbladder.
Download PDF
Return to publications
